+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global COVID-19 Antigen Test Market Size, Share & Trends Analysis Report by Product & Service (Reagents & Kits, Platforms), by End Use (Clinics & Hospitals, Home Care), by Region, and Segment Forecasts, 2021-2027

  • PDF Icon

    Report

  • 120 Pages
  • July 2021
  • Region: Global
  • Grand View Research
  • ID: 5390566
The global COVID-19 antigen test market size is expected to reach USD 8.3 billion by 2027. The market is estimated to expand at a CAGR of 6.7% from 2021 to 2027. A COVID-19 antigen test can help fill the gap in the testing landscape by enabling fast diagnoses in clinical settings. With the rising number of new infection cases coupled with the increasing popularity of antigen testing, a substantial number of companies are making significant attempts to boost their market presence in this arena, thereby driving the market.



Antigen-based screening for acute phase diagnosis is gaining momentum, as antigens are more evident in the sputum from the onset of symptoms. Moreover, integration of antigen detection in disease screening enables its use for PoC, community-wide, or door-to-door testing. This mode of testing can deliver results in real-time, and thus, help accelerate patient admission and treatment processes, leading to improved patient outcomes.

With the expected decline in COVID-19 cases, PoC tests can become critical in the determination of infected individuals and asymptomatic carriers to assure their isolation from the general population. While this test mode is currently unavailable for large-scale use, both private and public organizations across the globe are working on prototypes, with over 50 currently in development.

COVID-19 Antigen Test Market Report Highlights

  • The services segment dominated the market and accounted for the largest revenue share in 2020 owing to the increasing usage of Rapid Antigen Tests (RATs) by service providers including labs, hospitals, and others
  • The reagents and kits segment is anticipated to register the fastest CAGR over the forecast period due to the rising popularity of self-administered test kits
  • The clinics and hospitals segment dominated the market in 2020 with the highest test penetration in terms of usage in this end-use segment
  • The home care segment is projected to grow at a lucrative pace during the forecast period owing to the increased approval of over-the-counter tests with no prescription required
  • In Asia Pacific, the market captured maximum revenue share in 2020 with India as one of the key users of antigen tests
  • On the contrary, the approval and adoption of antigen tests in western countries is relatively slow
  • However, with the increase in the number of cases, in the U.S., key diagnostic developers have begun antigen test development and are planning to ship test kits in bulk to healthcare practitioners
  • The key players are engaged in collaboration with biopharma developers to support their product development process


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global COVID-19 Antigen Test Market

What is the estimated value of the Global COVID-19 Antigen Test Market?

The Global COVID-19 Antigen Test Market was estimated to be valued at $5.3 billion in 2020.

What is the growth rate of the Global COVID-19 Antigen Test Market?

The growth rate of the Global COVID-19 Antigen Test Market is 6.7%, with an estimated value of $8.3 billion by 2027.

What is the forecasted size of the Global COVID-19 Antigen Test Market?

The Global COVID-19 Antigen Test Market is estimated to be worth $8.3 billion by 2027.

Who are the key companies in the Global COVID-19 Antigen Test Market?

Key companies in the Global COVID-19 Antigen Test Market include ABBOTT, SD BIOSENSONSOR, INC., MYLAB DISCOVERY SOLUTIONS PVT. LTD., VISHAT DIAGNOSTIC PVT. LTD., GENBODY INC., F. HOFFMANN, LA ROCHE LTD., ACCESS BIO and PERKINELMER INC..

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective 1:
1.6.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Summary
Chapter 3 COVID-19 Antigen Test Market: Industry Outlook
3.1 Competitive Analysis- COVID-19 POC Testing
3.2 Market Trends & Outlook
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in product approvals by regulatory bodies
3.3.1.2 Rising cases coupled with emergence of novel COVID-19 strains
3.3.1.3 Key role of COVID tests in vaccine R&D
3.3.1.4 Paradigm shift towards Point-of-Care (POC) testing
3.3.2 Market restraint analysis
3.3.2.1 False and misleading results
3.3.2.2 Challenges in early detection of COVID-19 cases
3.3.3 Market opportunity analysis
3.3.3.1 Government initiatives for mass testing
3.3.4 Market challenge analysis
3.3.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
3.4 SWOT Analysis
3.5 Porter’s Five Forces Analysis
Chapter 4 Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
4.3 Vendor Landscape
4.3.1 Key company market share analysis, 2020
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Synergy analysis: major deals & strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies /technology disruptors/innovators
Chapter 5 COVID-19 Antigen Test Market: Product & Service Business Analysis
5.1 COVID-19 Antigen Test Market: Product & Service Movement Analysis
5.2 Reagents & Kits
5.2.1 COVID-19 antigen test market estimates and forecast for reagents & kits, 2020 - 2027 (USD Million)
5.3 Platforms
5.3.1 COVID-19 antigen test market estimates and forecast for platforms, 2020 - 2027 (USD Million)
5.4 Services
5.4.1 COVID-19 antigen test market estimates and forecast for services, 2020 - 2027 (USD Million)
Chapter 6 COVID-19 Antigen Test Market: End-Use Business Analysis
6.1 COVID-19 Antigen Test Market: End-use Movement Analysis
6.2 Diagnostic Labs
6.2.1 COVID-19 antigen test market estimates and forecast for diagnostic labs, 2020 - 2027 (USD Million)
6.3 Clinics & Hospitals
6.3.1 COVID-19 antigen test market estimates and forecast for clinics & hospitals, 2020 - 2027 (USD Million)
6.4 Home Care
6.4.1 COVID-19 antigen test market estimates and forecast for home care, 2020 - 2027 (USD Million)
6.5 Others
6.5.1 COVID-19 antigen test market estimates and forecast for other end-use, 2020 - 2027 (USD Million)
Chapter 7 COVID-19 Antigen Test Market: Regional Business Analysis
7.1 COVID-19 Antigen Test Market: Regional Movement Analysis, 2020 & 2027
7.2 North America
7.2.1 North America COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.2.2.2 U.S. COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.2.3.2 Canada COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3 Europe
7.3.1 Europe COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.2.2 Germany COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.3.2 U.K. COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3.4 France
7.3.4.1 France COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.4.2 France COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3.5 Italy
7.3.5.1 Italy COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.5.2 Italy COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3.6 Spain
7.3.6.1 Spain COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.6.2 Spain COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.3.7 Russia
7.3.7.1 Russia COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.3.7.2 Russia COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.4.2.2 Japan COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.4.3 China
7.4.3.1 China COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.4.3.2 China COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.4.4 India
7.4.4.1 India COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.4.4.2 India COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.4.5 South Korea
7.4.5.1 South Korea COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.4.5.2 South Korea COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.4.6 Australia
7.4.6.1 Australia COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.4.6.2 Australia COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.5.2.2 Brazil COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.5.3.2 Mexico COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.6 Middle East Africa
7.6.1 Middle East & Africa COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.6.2.2 South Africa COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia COVID-19 antigen test market estimates and forecast, by product & service scope 2020 - 2027 (USD Million)
7.6.3.2 Saudi Arabia COVID-19 antigen test market estimates and forecast, by end use scope 2020 - 2027 (USD Million)
Chapter 8 Company Profiles
8.1 Strategy framework
8.2 Company Profiles
8.2.1 ABBOTT
8.2.1.1 Company overview
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 SD BIOSENSONSOR, INC.
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 MYLAB DISCOVERY SOLUTIONS PVT. LTD.
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 VISHAT DIAGNOSTIC PVT. LTD.
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 GENBODY INC.
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 F. HOFFMANN-LA ROCHE LTD.
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.4 Strategic initiatives
8.2.7 ACCESS BIO
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.4 Strategic initiatives
8.2.8 ADS BIOTECH INC.
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 PERKINELMER INC.
8.2.9.1 Company overview
8.2.9.2 Financial performance
8.2.9.3 Product benchmarking
8.2.9.4 Strategic initiatives
8.2.10 PRINCETON BIOMEDITECH CORPORATION
8.2.10.1 Company overview
8.2.10.2 Financial performance
8.2.10.3 Product benchmarking
8.2.10.4 Strategic initiatives
8.2.11 BECTON, DICKINSON AND COMPANY (BD)
8.2.11.1 Company overview
8.2.11.2 Financial performance
8.2.11.3 Product benchmarking
8.2.11.4 Strategic initiatives
8.2.12 DIASORIN S.P.A
8.2.12.1 Company overview
8.2.12.2 Financial performance
8.2.12.3 Product benchmarking
8.2.12.4 Strategic initiatives
8.2.13 QUIDEL CORPORATION
8.2.13.1 Company overview
8.2.13.2 Financial performance
8.2.13.3 Product benchmarking
8.2.13.4 Strategic initiatives
8.2.14 LABORATORY CORPORATION OF AMERICA
8.2.14.1 Company overview
8.2.14.2 Financial performance
8.2.14.3 Product benchmarking
8.2.14.4 Strategic initiatives
List of Tables
Table 1 Competitive analysis- COVID-19 POC testing
Table 2 The U.S. FDA approved individual EUAs for antigen diagnostic tests for SARS-CoV-2
Table 3 Recent developments by key participants
Table 4 Major deals & strategic alliances
Table 5 List of emerging companies
Table 6 Approved COVID-19 antigen testing platforms by WHO, EUL
Table 7 North America COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 8 North America COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 9 U.S. COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 10 U.S. COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 11 Canada COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 12 Canada COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 13 Europe COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 14 Europe COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 15 Germany COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 16 Germany COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 17 U.K. COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 18 U.K. COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 19 France COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 20 France COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 21 Italy COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 22 Italy COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 23 Spain COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 24 Spain COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 25 Russia COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 26 Russia COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 27 Asia Pacific COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 28 Asia Pacific COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 29 Japan COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 30 Japan COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 31 China COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 32 China COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 33 South Korea COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 34 South Korea COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 35 India COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 36 India COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 37 Australia COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 38 Australia COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 39 Latin America COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 40 Latin America COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 41 Brazil COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 42 Brazil COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 43 Mexico COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 44 Mexico COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 45 MEA COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 46 MEA COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 47 South Africa COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 48 South Africa COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
Table 49 Saudi Arabia COVID-19 antigen test market, by product & service scope 2020 - 2027 (USD Million)
Table 50 Saudi Arabia COVID-19 antigen test market, by end use scope 2020 - 2027 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market Segmentation
Fig. 9 Market summary, 2020 (USD Million)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 SWOT Analysis, By Factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 COVID-19 antigen test market company/competition categorization
Fig. 16 COVID-19 antigen test market company market share analysis
Fig. 17 COVID-19 antigen test market company market position analysis
Fig. 18 COVID-19 antigen test market: Product & service outlook and key takeaways
Fig. 19 COVID-19 antigen test market: Product & service movement analysis
Fig. 20 COVID-19 antigen test market estimates and forecast for reagents & kits, 2020 - 2027 (USD Million)
Fig. 21 COVID-19 antigen test market estimates and forecast for platforms, 2020 - 2027 (USD MILLION)
Fig. 22 COVID-19 antigen test market estimates and forecast for services, 2020 - 2027 (USD MILLION)
Fig. 23 COVID-19 antigen test market: End-use outlook key takeaways
Fig. 24 COVID-19 antigen test market: End-use movement analysis
Fig. 25 COVID-19 antigen test market estimates and forecast for diagnostic laboratories, 2020 - 2027 (USD MILLION)
Fig. 26 COVID-19 antigen test market estimates and forecast for clinics and hospitals, 2020 - 2027 (USD MILLION)
Fig. 27 COVID-19 antigen test market estimates and forecast for home care, 2020 - 2027 (USD Million)
Fig. 28 COVID-19 antigen test market estimates and forecast for other end-use, 2020 - 2027 (USD Million)
Fig. 29 COVID-19 antigen test market: Regional outlook & key takeaways
Fig. 30 COVID-19 antigen test market: Regional movement analysis
Fig. 31 North America COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 32 U.S. COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 33 Canada COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 34 Europe COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 35 Germany COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 36 U.K. COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 37 France COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 38 Italy COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 39 Spain COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 40 Russia COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 41 Asia Pacific COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 42 Japan COVID-19 Antigen Test Market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 43 China COVID-19 Antigen Test Market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 44 South Korea COVID-19 Antigen Test Market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 45 India COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 46 Australia COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 47 Latin America COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 48 Brazil COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 49 Mexico COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 50 Middle East Africa COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 51 South Africa COVID-19 Antigen Test Market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 52 Saudi Arabia COVID-19 antigen test market estimates and forecast, 2020 - 2027 (USD Million)
Fig. 53 Strategy framework

Companies Mentioned

  • ABBOTT
  • SD BIOSENSONSOR, INC.
  • MYLAB DISCOVERY SOLUTIONS PVT. LTD.
  • VISHAT DIAGNOSTIC PVT. LTD.
  • GENBODY INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • ACCESS BIO
  • ADS BIOTECH INC.
  • PERKINELMER INC.
  • PRINCETON BIOMEDITECH CORPORATION
  • BECTON, DICKINSON AND COMPANY (BD)
  • DIASORIN S.P.A
  • QUIDEL CORPORATION
  • LABORATORY CORPORATION OF AMERICA

Methodology

Loading
LOADING...